CIMGOTCRetail-Miscellaneous RetailFiscal year ends September 30
CIMG Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.00+0.00 (+4.76%)
Close on Oct 19, 2026
- Market cap
- $298.83K
- P/E (TTM)
- –
- Dividend yield
- –
CIMG Inc. revenue by segment
By business segment
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Computing Power Product Series [Member] | $2.05M | $2.65M | $2.36M | – | – | – | – | – | – | – | – | – | 94.3% | – |
| Maca Product [Member] | $108.94K | $136.42K | $11.98M | – | – | – | – | – | – | – | – | – | 5.0% | – |
| Homology of Medicine and Food Series [Member] | $15.46K | $428.79K | $1.43M | – | – | – | – | – | – | – | – | – | 0.7% | – |
| Operating income | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Homology of Medicine and Food Series [Member] | $26 | $115.16K | -$137.16K | – | – | – | – | – | – | – | – | – | – |
| Maca Product [Member] | $0 | $0 | -$270.82K | – | – | – | – | – | – | – | – | – | – |
| Computing Power Product Series [Member] | -$8.07K | -$46.97K | $36.93K | – | – | – | – | – | – | – | – | – | – |
| Others Unallocated Headquarter Costs [Member] | -$845.97K | -$1.39M | -$1.62M | – | – | – | – | – | – | – | – | – | – |
By product or service
By region
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | $2.17M | $3.21M | $15.77M | $10.21M | $61.58K | $0 | $22.85K | – | – | – | – | – | 100.0% | +3426.1% |
| North America [Member] | – | – | – | – | – | – | – | $282.34K | $352.62K | $323.41K | $965.93K | $462.63K | – | – |
| South Korea | – | – | – | – | – | – | – | – | – | $282.36K | $388.05K | $320.08K | – | – |
From the segment and revenue-disaggregation notes of CIMG's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.